Found: 406
Select item for more details and to access through your institution.
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses.
- Published in:
- 2017
- By:
- Publication type:
- journal article
RASS‐Enabled S/P−C and S−N Bond Formation for DEL Synthesis.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 19, p. 7447, doi. 10.1002/ange.201915493
- By:
- Publication type:
- Article
Conformational Studies and Atropisomerism Kinetics of the ALK Clinical Candidate Lorlatinib (PF-06463922) and Desmethyl Congeners.
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 11, p. 3654, doi. 10.1002/ange.201509240
- By:
- Publication type:
- Article
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1448, doi. 10.1007/s10637-020-00915-4
- By:
- Publication type:
- Article
Multiple myeloma: A prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment.
- Published in:
- Journal of Cellular Biochemistry, 2007, v. 101, n. 4, p. 950, doi. 10.1002/jcb.21213
- By:
- Publication type:
- Article
Wind turbine SCADA alarm analysis for improving reliability.
- Published in:
- Wind Energy, 2012, v. 15, n. 8, p. 951, doi. 10.1002/we.513
- By:
- Publication type:
- Article
The multi-scale influence of topography on lava flow morphology.
- Published in:
- Bulletin of Volcanology, 2019, v. 81, n. 4, p. N.PAG, doi. 10.1007/s00445-019-1278-9
- By:
- Publication type:
- Article
A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1595, doi. 10.1002/ajh.26361
- By:
- Publication type:
- Article
Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA‐MM subgroup analysis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. E423, doi. 10.1002/ajh.26319
- By:
- Publication type:
- Article
Patient‐reported health‐related quality of life from the phase III TOURMALINE‐MM1 study of ixazomib‐lenalidomide‐dexamethasone versus placebo‐lenalidomide‐dexamethasone in relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 8, p. 985, doi. 10.1002/ajh.25134
- By:
- Publication type:
- Article
TAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 400, doi. 10.1002/ajh.24300
- By:
- Publication type:
- Article
TAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non- Hodgkin lymphoma, or Waldenström's macroglobulinemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 400, doi. 10.1002/ajh.24300
- By:
- Publication type:
- Article
Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. 314, doi. 10.1002/ajh.23933
- By:
- Publication type:
- Article
A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 7, p. 573, doi. 10.1002/ajh.22048
- By:
- Publication type:
- Article
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 9, p. 670, doi. 10.1002/ajh.21788
- By:
- Publication type:
- Article
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 9, p. 831, doi. 10.1002/ajh.20961
- By:
- Publication type:
- Article
The Role of Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Multiple Myeloma: Is It Time to Rethink the Paradigm in the Era of Targeted Therapy?
- Published in:
- Hemato, 2024, v. 5, n. 2, p. 144, doi. 10.3390/hemato5020012
- By:
- Publication type:
- Article
Extrinsic and intrinsic cue effects on perceptions of store brand quality.
- Published in:
- Journal of Marketing, 1994, v. 58, n. 4, p. 28, doi. 10.1177/002224299405800403
- By:
- Publication type:
- Article
Fine-scale spatial heterogeneity and incoming seed diversity additively determine plant establishment.
- Published in:
- Journal of Ecology, 2012, v. 100, n. 4, p. 939, doi. 10.1111/j.1365-2745.2011.01948.x
- By:
- Publication type:
- Article
Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 2, p. 378, doi. 10.3390/cells9020378
- By:
- Publication type:
- Article
Activation of NF-KB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
- Published in:
- Oncogene, 2002, v. 21, n. 37, p. 5673, doi. 10.1038/sj.onc.1205664
- By:
- Publication type:
- Article
Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays.
- Published in:
- Oncogene, 2002, v. 21, n. 9, p. 1346, doi. 10.1038/sj.onc.1205205
- By:
- Publication type:
- Article
The role of tumor necrosis factor α in the pathophysiology of human multiple myeloma: therapeutic applications.
- Published in:
- Oncogene, 2001, v. 20, n. 33, p. 4519, doi. 10.1038/sj.onc.1204623
- By:
- Publication type:
- Article
IgA multiple myeloma in a patient with an IgG pemphigus foliaceus-like exanthem.
- Published in:
- International Journal of Dermatology, 2017, v. 56, n. 10, p. 1058, doi. 10.1111/ijd.13721
- By:
- Publication type:
- Article
Thalidomide- and Lenalidomide-Associated Thromboembolism Among Patients With Cancer.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow‐up subgroup analysis of the BOSTON trial.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 2, p. 242, doi. 10.1111/ejh.14223
- By:
- Publication type:
- Article
Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 402, doi. 10.1111/ejh.14127
- By:
- Publication type:
- Article
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 1, p. 73, doi. 10.1111/ejh.13706
- By:
- Publication type:
- Article
Clinical benefit of ixazomib plus lenalidomide‐dexamethasone in myeloma patients with non‐canonical NF‐κB pathway activation.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 274, doi. 10.1111/ejh.13435
- By:
- Publication type:
- Article
Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 6, p. 494, doi. 10.1111/ejh.13231
- By:
- Publication type:
- Article
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 3, p. 199, doi. 10.1111/ejh.12903
- By:
- Publication type:
- Article
Phase II Studies in Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S40
- By:
- Publication type:
- Article
Bortezomib-Induced Tumor Lysis Syndrome in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 3, p. 233
- By:
- Publication type:
- Article
Emerging Trends in the Clinical Use of Bortezomib in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2005, v. 6, n. 2, p. 84
- By:
- Publication type:
- Article
Multiple infection and HIV superinfection among persons who inject drugs in Indonesia and Ukraine.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 12, p. 2181, doi. 10.1093/infdis/jiac441
- By:
- Publication type:
- Article
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone disease.
- Published in:
- BMC Genomics, 2014, v. 15, n. 1, p. 904, doi. 10.1186/1471-2164-15-904
- By:
- Publication type:
- Article
Remembering Donald Paul Hustad, FHS.
- Published in:
- 2013
- By:
- Publication type:
- Obituary
Continued Progress in Treatment Options for Multiple Myeloma: From Past to Present and Future.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 12, p. 1511
- By:
- Publication type:
- Article
Novel Therapeutic Avenues in Myeloma: Changing the Treatment Paradigm.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 7, p. 785
- By:
- Publication type:
- Article
New Treatment Options for Patients in First Relapse.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 6, p. 633
- By:
- Publication type:
- Article
New Treatments for Multiple Myeloma.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 14, p. 1781
- By:
- Publication type:
- Article
Strain-resolved community proteomics reveals recombining genomes of acidophilic bacteria.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Community structure and metabolism through reconstruction of microbial genomes from the environment.
- Published in:
- Nature, 2004, v. 428, n. 6978, p. 37, doi. 10.1038/nature02340
- By:
- Publication type:
- Article
Fifty‐eight years and counting of watershed science at the Caspar Creek Experimental Watersheds in northern California.
- Published in:
- Hydrological Processes, 2021, v. 35, n. 6, p. 1, doi. 10.1002/hyp.14207
- By:
- Publication type:
- Article
Direct topsoil transfer to already planted reforestation sites increases native plant understory and not ruderals.
- Published in:
- Restoration Ecology, 2024, v. 32, n. 3, p. 1, doi. 10.1111/rec.14076
- By:
- Publication type:
- Article
Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45626-w
- By:
- Publication type:
- Article
Complete genome sequence of the Antarctic Halorubrum lacusprofundi type strain ACAM 34.
- Published in:
- Standards in Genomic Sciences, 2016, v. 11, p. 1, doi. 10.1186/s40793-016-0194-2
- By:
- Publication type:
- Article
Complete genome sequence of the facultatively chemolithoautotrophic and methylotrophic alpha Proteobacterium Starkeya novella type strain (ATCC 8093<sup>T</sup>).
- Published in:
- 2012
- By:
- Publication type:
- Art Reproduction
Synthesis and Investigation of 2,3,5,6-Tetra-(1H-tetrazol-5-yl)pyrazine Based Energetic Materials.
- Published in:
- ChemPlusChem, 2018, v. 83, n. 11, p. 984, doi. 10.1002/cplu.201800414
- By:
- Publication type:
- Article